Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sturgill

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancers|January 17, 2019
Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor CellsJesus I Luna, Steven K Grossenbacher, Ian R Sturgill, et al.
Glycobiology|June 28, 2012
Biosynthesis of the major brain gangliosides GD1a and GT1bElizabeth R Sturgill, Kazuhiro Aoki, Pablo H H Lopez, et al.
International Journal of Molecular Sciences|March 28, 2024
Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue SarcomasSylvia M Cruz, Khurshid R Iranpur, Sean J Judge, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trialRobert J Canter, Steven K Grossenbacher, Jennifer A Foltz, et al.
Science Translational Medicine|April 9, 2025
The response to anti-PD-1 and anti-LAG-3 checkpoint blockade is associated with regulatory T cell reprogrammingAnnah S Rolig, Xiyu Peng, Elizabeth R Sturgill, et al.
Plos One|February 22, 2020
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transferSean J Judge, Mio Yanagisawa, Ian R Sturgill, et al.
The Journal of Clinical Investigation|March 6, 2020
Minimal PD-1 expression in mouse and human NK cells under diverse conditionsSean J Judge, Cordelia Dunai, Ethan G Aguilar, et al.
Journal for Immunotherapy of Cancer|November 7, 2020
Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomasSean J Judge, Morgan A Darrow, Steve W Thorpe, et al.
Plos Pathogens|September 1, 2016
Natural Killer Cell Evasion Is Essential for Infection by Rhesus CytomegalovirusElizabeth R Sturgill, Daniel Malouli, Scott G Hansen, et al.
Journal for Immunotherapy of Cancer|April 10, 2021
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitorBrendan D Curti, Yoshinobu Koguchi, Rom S Leidner, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancers|January 17, 2019
Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor CellsJesus I Luna, Steven K Grossenbacher, Ian R Sturgill, et al.
Glycobiology|June 28, 2012
Biosynthesis of the major brain gangliosides GD1a and GT1bElizabeth R Sturgill, Kazuhiro Aoki, Pablo H H Lopez, et al.
International Journal of Molecular Sciences|March 28, 2024
Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue SarcomasSylvia M Cruz, Khurshid R Iranpur, Sean J Judge, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trialRobert J Canter, Steven K Grossenbacher, Jennifer A Foltz, et al.
Science Translational Medicine|April 9, 2025
The response to anti-PD-1 and anti-LAG-3 checkpoint blockade is associated with regulatory T cell reprogrammingAnnah S Rolig, Xiyu Peng, Elizabeth R Sturgill, et al.
Plos One|February 22, 2020
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transferSean J Judge, Mio Yanagisawa, Ian R Sturgill, et al.
The Journal of Clinical Investigation|March 6, 2020
Minimal PD-1 expression in mouse and human NK cells under diverse conditionsSean J Judge, Cordelia Dunai, Ethan G Aguilar, et al.
Journal for Immunotherapy of Cancer|November 7, 2020
Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomasSean J Judge, Morgan A Darrow, Steve W Thorpe, et al.
Plos Pathogens|September 1, 2016
Natural Killer Cell Evasion Is Essential for Infection by Rhesus CytomegalovirusElizabeth R Sturgill, Daniel Malouli, Scott G Hansen, et al.
Journal for Immunotherapy of Cancer|April 10, 2021
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitorBrendan D Curti, Yoshinobu Koguchi, Rom S Leidner, et al.
Pageof 3